BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37119854)

  • 21. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
    Sever S; Schiffer M
    Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synaptopodin Limits TRPC6 Podocyte Surface Expression and Attenuates Proteinuria.
    Yu H; Kistler A; Faridi MH; Meyer JO; Tryniszewska B; Mehta D; Yue L; Dryer S; Reiser J
    J Am Soc Nephrol; 2016 Nov; 27(11):3308-3319. PubMed ID: 27020855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preservations of nephrin and synaptopodin by recombinant hepatocyte growth factor in podocytes for the attenuations of foot process injury and albuminuria in nephritic mice.
    Kato T; Mizuno S; Nakamura T
    Nephrology (Carlton); 2011 Mar; 16(3):310-8. PubMed ID: 21342325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis.
    Feng D; Kumar M; Muntel J; Gurley SB; Birrane G; Stillman IE; Ding L; Wang M; Ahmed S; Schlondorff J; Alper SL; Ferrante T; Marquez SL; Ng CF; Novak R; Ingber DE; Steen H; Pollak MR
    J Am Soc Nephrol; 2020 Jul; 31(7):1479-1495. PubMed ID: 32540856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
    Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
    Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-Actinin-4 is involved in the process by which dexamethasone protects actin cytoskeleton stabilization from adriamycin-induced podocyte injury.
    Liu H; Gao X; Xu H; Feng C; Kuang X; Li Z; Zha X
    Nephrology (Carlton); 2012 Nov; 17(8):669-75. PubMed ID: 22804863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-sulfation of heparan sulfate is critical for syndecan-4-mediated podocyte cell-matrix interactions.
    Sugar T; Wassenhove-McCarthy DJ; Orr AW; Green J; van Kuppevelt TH; McCarthy KJ
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1123-35. PubMed ID: 26936875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling.
    Dai C; Stolz DB; Bastacky SI; St-Arnaud R; Wu C; Dedhar S; Liu Y
    J Am Soc Nephrol; 2006 Aug; 17(8):2164-75. PubMed ID: 16837631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
    Sistani L; Dunér F; Udumala S; Hultenby K; Uhlen M; Betsholtz C; Tryggvason K; Wernerson A; Patrakka J
    Kidney Int; 2011 Nov; 80(10):1045-54. PubMed ID: 21814175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
    Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies.
    Ye Q; Lan B; Liu H; Persson PB; Lai EY; Mao J
    Acta Physiol (Oxf); 2022 Aug; 235(4):e13850. PubMed ID: 35716094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes.
    Michaud JL; Chaisson KM; Parks RJ; Kennedy CR
    Kidney Int; 2006 Sep; 70(6):1054-61. PubMed ID: 16837921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyposialylated angiopoietin-like-4 induces apoptosis of podocytes via β1 Integrin/FAK signaling in diabetic nephropathy.
    Guo K; Pan P; Wu M; Ma Y; Lu J; Chen H
    Mol Cell Endocrinol; 2020 Apr; 505():110730. PubMed ID: 31981598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-actinin-4 is required for normal podocyte adhesion.
    Dandapani SV; Sugimoto H; Matthews BD; Kolb RJ; Sinha S; Gerszten RE; Zhou J; Ingber DE; Kalluri R; Pollak MR
    J Biol Chem; 2007 Jan; 282(1):467-77. PubMed ID: 17082197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
    Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
    J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-actinin-1 phosphorylation modulates pressure-induced colon cancer cell adhesion through regulation of focal adhesion kinase-Src interaction.
    Craig DH; Haimovich B; Basson MD
    Am J Physiol Cell Physiol; 2007 Dec; 293(6):C1862-74. PubMed ID: 17898132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes.
    Hsu HH; Hoffmann S; Endlich N; Velic A; Schwab A; Weide T; Schlatter E; Pavenstädt H
    J Mol Med (Berl); 2008 Dec; 86(12):1379-94. PubMed ID: 18773185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephron, Wilms' tumor-1 (WT1), and synaptopodin expression in developing podocytes of mice.
    Kato T; Mizuno S
    Exp Anim; 2017 Aug; 66(3):183-189. PubMed ID: 28179596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plectin protects podocytes from adriamycin-induced apoptosis and F-actin cytoskeletal disruption through the integrin α6β4/FAK/p38 MAPK pathway.
    Ni Y; Wang X; Yin X; Li Y; Liu X; Wang H; Liu X; Zhang J; Gao H; Shi B; Zhao S
    J Cell Mol Med; 2018 Nov; 22(11):5450-5467. PubMed ID: 30187999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mice with podocyte-specific overexpression of wild type alpha-actinin-4 are healthy controls for K256E-alpha-actinin-4 mutant transgenic mice.
    Michaud JL; Stitt-Cavanaugh E; Endlich N; Endlich K; De Repentigny Y; Kothary R; Kennedy CR
    Transgenic Res; 2010 Apr; 19(2):285-9. PubMed ID: 19585264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.